From Nasdaq, Inc.: 2025-06-08 05:41:00

UnitedHealth Group, a Dow Jones favorite, has seen its stock price drop over 50%. Facing challenges since last year, including a cyberattack, disappointing earnings, and CEO murder. 2025 brought more bad news with lower-than-expected earnings and membership changes. DOJ launched a criminal investigation, and President Trump threatened PBMs. Temporary issues may be resolved, and the CEO turnover isn’t concerning. With stock at a low price-to-earnings ratio, is now a good time to buy? The Motley Fool thinks so, suggesting UnitedHealth Group as a potential buy for patient investors.



Read more at Nasdaq, Inc.: Is UnitedHealth Group Stock a Brilliant Bad News Buy?